CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 


<
Alexion Pharmaceuticals, Inc.  (ALXN)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 


 

Alexion Pharmaceuticals, Inc.

ALXN's Financial Statements and Analysis






Alexion Pharmaceuticals, Inc. reported II. Quarter net loss per share of $-2.05 compare to earnings per share of $0.73 in the same quarter a year ago a decrease from $1.11 eps realized in I. Quarter (Mar 31 2018).

Alexion Pharmaceuticals's Revenue rose by % in II. Quarter (Jun 30 2018) year on year, to $1,045 million and advanced by 12.26 % sequentially.


Alexion Pharmaceuticals is Expected to report next financial results on February 11, 2019.
More on ALXN's Income Statement

II. Quarter
Earnings Per Share Revenues
$ -2.05 $  1,045 Mill
$-2.78     $+133M     +14.58 %
You need to upgrade your Flash Player
ALXN's NET INCOME

Alexion Pharmaceuticals's in II. Quarter recorded net loss of $-457 million, compare to net income of $165 million achieved in II. Quarter a year ago.

Sequentially company realized net loss, compare to net income of $249.10 million in previous quarter.

More on ALXN's Growth

Inventories Inventories grew by 12.98 % to $463 million from II. Quarter a year ago, sequentially inventories rose by 1.47 %. In II. Quarter company's net cash and cash equivalents decreased by $0 million, capital expenditures grew by -37.20%, to $-63 millions compare to same quarter a year ago and rose by -5.71% from I. Quarter (Mar 31 2018).

More on ALXN's Cash flow Statement



Alexion Pharmaceuticals, Inc. does not pay out common stock dividend.

In trailing twelve-month period Alexion Pharmaceuticals, Inc. earned $ 2.17 cash per share, on a free-cash flow basis .

Book value fell by -3.31 % sequentially to $39.39 per share, -293.46% of net loss per share in trailing twelve-month period were subtructed from shareholder value.


Company repurchased 1.10 million shares or 0.49 % in II. Quarter.
Interest Coverage Ratio was 1.81. Debt Coverage Ratio was 0.06.

More on ALXN's Dividends
 Market Capitalization (Millions) 27,606
 Shares Outstanding (Millions) 223
 Total Debt (Millions $) 2,593
 Revenue (TTM) (Millions $) 3,745
 Net Income (TTM) (Millions $) -100
 Cash Flow (TTM) (Millions $) 42
 Capital Exp. (TTM) (Millions $) -312
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 2,273





Alexion Pharmaceuticals, Inc. does not pay out common stock dividend.

In trailing twelve-month period Alexion Pharmaceuticals, Inc. earned $ 2.17 cash per share, on a free-cash flow basis .

Book value fell by -3.31 % sequentially to $39.39 per share, -293.46% of net loss per share in trailing twelve-month period were subtructed from shareholder value.


Company repurchased 1.10 million shares or 0.49 % in II. Quarter.
Interest Coverage Ratio was 1.81. Debt Coverage Ratio was 0.06.

More on ALXN's Dividends
 Market Capitalization (Millions) 27,606
 Shares Outstanding (Millions) 223
 Total Debt (Millions $) 2,593
 Revenue (TTM) (Millions $) 3,745
 Net Income (TTM) (Millions $) -100
 Cash Flow (TTM) (Millions $) 42
 Capital Exp. (TTM) (Millions $) -312
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 2,273


   

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SFHI's Profile

Stock Price

SFHI's Financials

Business Description

Fundamentals

Charts & Quotes

SFHI's News

Suppliers

SFHI's Competitors

Customers & Markets

Economic Indicators

SFHI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071